CF
Insider selling
Chris Freeman sold $10.8M of GH stock
Chris Freeman, Chief Commercial Officer of Guardant Health, Inc. (GH), sold 63,605 shares of GH stock worth $10.8M, per an SEC Form 4 filed Aug 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 10, 2026, 1 day before it was made public.
GH has moved +10.8% since the trade date, from $167.21 to $185.31 (Oct 29, 2026 close).
- Traded
- Aug 10, 2026
- Disclosed
- Aug 11, 2026
- Filing delay
- 1 day
- Price since
- +10.8%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4
More GH insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.